Deletion of Wiskott-Aldrich syndrome protein triggers Rac2 activity and increased cross-presentation by dendritic cells.
Marisa A P BaptistaMarton KeszeiMariana OliveiraKaren K S SunaharaJohn AnderssonCarin I M DahlbergAusten J WorthAgne LiedénI-Chun KuoRobert P A WallinScott B SnapperLiv EidsmoAnnika ScheyniusMikael C I KarlssonGerben BoumaSiobhan O BurnsMattias N E ForsellAdrian J ThrasherSusanne NylénLisa S WesterbergPublished in: Nature communications (2016)
Wiskott-Aldrich syndrome (WAS) is caused by loss-of-function mutations in the WASp gene. Decreased cellular responses in WASp-deficient cells have been interpreted to mean that WASp directly regulates these responses in WASp-sufficient cells. Here, we identify an exception to this concept and show that WASp-deficient dendritic cells have increased activation of Rac2 that support cross-presentation to CD8(+) T cells. Using two different skin pathology models, WASp-deficient mice show an accumulation of dendritic cells in the skin and increased expansion of IFNγ-producing CD8(+) T cells in the draining lymph node and spleen. Specific deletion of WASp in dendritic cells leads to marked expansion of CD8(+) T cells at the expense of CD4(+) T cells. WASp-deficient dendritic cells induce increased cross-presentation to CD8(+) T cells by activating Rac2 that maintains a near neutral pH of phagosomes. Our data reveals an intricate balance between activation of WASp and Rac2 signalling pathways in dendritic cells.
Keyphrases
- dendritic cells
- regulatory t cells
- immune response
- lymph node
- induced apoptosis
- case report
- squamous cell carcinoma
- signaling pathway
- oxidative stress
- endoplasmic reticulum stress
- cell death
- gene expression
- radiation therapy
- dna methylation
- small molecule
- copy number
- machine learning
- sentinel lymph node
- wild type
- protein protein